Costs of Medically Sound Cancer Immunotherapies Available in Mexico

This document summarizes the typical pricing for scientifically credible but non‑FDA‑approved cancer immunotherapies offered in Mexico. These therapies include dendritic cell vaccines, NK‑cell therapy, and combined immunotherapy programs. They are biologically plausible and used in research worldwide, but in the United States they are restricted to clinical trials.

Dendritic Cell (DC) Vaccines

Dendritic cell vaccines are custom‑engineered immune therapies designed to train the immune system to recognize tumor antigens. Mexico permits clinical use, while the U.S. limits access to research trials.

Cost Range	$15,000–$25,000 per protocol; up to $110,000 for expanded multi‑week programs
Cost Drivers	Antigen preparation, number of infusions, combination with NK‑cell therapy or checkpoint inhibitors

Natural Killer (NK) Cell Therapy

NK‑cell therapy uses expanded natural killer cells to target cancer cells. It is scientifically credible and used in early‑phase trials globally. Mexico allows clinical use; the U.S. restricts it to investigational settings.

Cost Range	$10,000–$30,000 per cycle; $15,000–$50,000 at major centers
Session Pricing	$5,000–$15,000 per infusion session
U.S. Comparison	Investigational NK therapy in the U.S. can cost $200,000–$400,000

Off‑Label Immunotherapy Combinations

Mexico permits certain immunotherapy combinations—such as checkpoint inhibitors paired with cellular vaccines—that U.S. oncologists cannot prescribe outside clinical trials.

Standard Immunotherapy	$7,000–$11,000 per session (Keytruda, Opdivo)
Combination Programs	$5,000–$12,000 per cycle
Multi‑Week Packages	$18,000–$45,000

Combined Cellular Immunotherapy Programs

These programs integrate dendritic cells, NK cells, cytokine‑induced killer cells, and checkpoint inhibitors into a single treatment course.

Cost Range	$30,000–$90,000 for full multi‑week courses
Prostate Cancer Programs	$18,000–$45,000

Cost Comparison: Mexico vs. United States

Therapy Type	Mexico Cost	U.S. Availability	U.S. Cost
Dendritic Cell Vaccine	$15k–$25k (up to $110k)	Trials only	Not sold clinically
NK‑Cell Therapy	$10k–$50k	Trials only	$200k–$400k
Checkpoint Inhibitors	$7k–$11k/session	FDA‑approved	$30k/session
Combined Immunotherapy	$18k–$90k	Not allowed outside trials	Not available

Key Takeaway

Medically sound but non‑FDA‑approved cancer immunotherapies in Mexico typically cost $15,000–$50,000 per treatment cycle. These prices are substantially lower than investigational equivalents in the United States, where similar therapies can exceed $200,000–$400,000.

For any medical decision, consult a qualified healthcare professional. This document provides general information only and does not constitute personalized medical advice.